With Roe overturned, Trump’s GOP turns to transgender health care
It may be difficult for a new administration to stop drug negotiations before 2026, when the first round of drugs under Medicare Part D are open to negotiation.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.